Crude oil prices are down today. US wholesale inventories increased by 0.1% in August compared to a 0.2% rise in July. This could mean that there may be more oil supply than demand, which could lead to lower prices. Read from source...

failed to explain how the plaintiffs could have won if the allegations were true, and failed to explain why there was a 4-year delay in filing the lawsuit, especially since the person whose rights were allegedly violated made no claim to the police. Critics also argue that the media has continued to report on these allegations without mentioning the inconsistencies and that the article's title suggests that the allegations have been proven, which they argue is not the case.

Neutral

Posted in: Benzinga.com, Trading Ideas, Intraday Update, Markets, Mid Day Market Update, Intraday Trading, Markets Insights, Stocks, Trading News

### Tagged: Crude Oil, Economic Calendar, M&A Calendar, Stock Split Calendar, Trade Ideas, Trading News

Average Sentiment Score: 2.91

Average Sentiment Score (1-10): 6.17

Analysis of Sentiment Score:
Positive: 4
Negative: 2
Neutral: 4

This article contains content from multiple sources. The statements, opinions and data contained are solely those of the respective authors and contributors and not of Bitcoinist and its editor(s).

This article is not an endorsement or recommendation for any particular cryptocurrency, exchange or investment strategy. Bitcoinist and its editor(s) advise users to conduct their own research before making any investment decisions.

Bitcoinist is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article.

This content has been generated by a third party, Stock Market Wire, and has not been checked or verified by Stock Market Wire editors for factual accuracy or any other matter. Stock Market Wire is a third-party content provider, not an advisor or recommender and does not provide personalized financial advice. Stock Market Wire is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article.

The content on this website is provided for informational purposes only and does not constitute an offer of any financial product, nor is it financial advice, an invitation to purchase or sell securities, an invitation to engage in trading activities or investment activities, an invitation to engage in structured products or investment management activities.

The information on this website is not directed at any particular individual or group of individuals, nor is it intended for use by minors, or those without the requisite expertise. It is expressly prohibited for any person or persons in any jurisdiction or country, to utilize or rely upon any content available on this website in a way which is contrary to the applicable laws, rules and regulations in such jurisdiction or country.

The information on this website is not directed at any particular individual or group of individuals, nor is it intended for use by minors, or those without the requisite expertise. It is expressly prohibited for any person or persons in any jurisdiction or country, to utilize or rely upon any

News and information are not suitable for trading. Trading on financial markets is risky and can lead to significant financial loss. Only trade with money you can afford to lose. When deciding to trade, you should consider your investment goals, your level of experience and risk tolerance. Trading involves significant risk of loss. We strongly advise that you consult a certified financial advisor and conduct your own thorough research before making any investment decisions. Disclaimer: The website's content and the content of the newsletter are not a recommendation to buy or sell any securities or to make any sort of investment. The newsletter is an informational publication and a source of information. It is not an investment guide. Our information is based on sources considered to be reliable, but not guaranteed to be accurate or complete. The information contained in this website is not intended to provide tax, legal, or investment advice, and nothing on the website or in the newsletter should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Systematic Income or any third party. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should consult an attorney or tax professional regarding your specific legal or tax situation. You should also consult a licensed financial advisor or broker-dealer regarding your specific investment, trading or tax situation. For more information about the risks associated with trading, see the<|im_start|>ads.gov. For more information about the risks associated with trading, see the risk disclosure provided by your broker-dealer, exchange, or clearing firm. SECURITIES DISCLAIMER: Systematic Income is not a registered broker-dealer, investment advisor, or investment manager. You acknowledge that no communication, either orally or in writing, should be construed as a recommendation to enter into any transaction or contribute capital. You further acknowledge that Systematic Income does not offer or sell securities, and is not offering to buy or sell any security or instrument. You should only enter into transactions or contribute capital with a broker-dealer, investment advisor or investment manager with which you have a written agreement or other communication confirming the nature of the relationship and terms of the engagement.

4375total visits,1visits today

### AI:

Shares of Editas Medicine Inc. EDIT reported a 7.50% rise and closed at $32.95 on Oct 3. The company offered 5,300,000 shares of its common stock at $30.00 per share. The gross proceeds from the offering are expected to be approximately $159 million. The company plans to use the net proceeds for research and development, working capital